In this article, we will discuss Durvalumab (Warnings-32). So, let’s get started.
Musculoskeletal and connective tissue disorders: Myositis/polymyositis, rhabdomyolysis, and associated
sequelae, including renal failure, arthritis, polymyalgia rheumatic.